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ABSTRACT
The present study was aimed at determining the compounds available in Eleusine indica methanol extract and the effects on 
herpes simplex virus type 1 (HHV1) replication cycle and progeny infectivity. Twelve compounds mostly from the flavonoid 
and phenolic groups were identified by Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) analysis. The 
effect on replication phases of HHV1 was determined by time-of-addition, time-removal and virus yield reduction assays 
with expression of selected genes analysed by quantitative Real Time-Polymerase Chain Reaction (qRT-PCR). The extract 
inhibited plaque formation the most during the first 2 h and at 24 h of infection. Plaque formation inhibition was also 
noted at all other time points but at lesser percentage. Treatment with E. indica reduced progeny infectivity when treated 
for 10 h and was dose-dependent. E. indica methanol extract inhibited immediate early, early and late phases of HHV1 






30 genes during the infection. Immunostaining of 
infected cells confirmed that E. indica inhibited mainly Glycoproteins B but not Glycoprotein C and D. Thus, the methanol 
extract of E. indica has the ability to alter HHV1 replication cycle at almost all stages and reduce progeny infectivity. 
Keywords:  Eleusine indica methanol extract; HHV1 replication cycle; progeny infectivity 
ABSTRAK
Kajian ini bertujuan menentukan sebatian yang hadir dalam ekstrak metanol  Eleusine  indica serta kesan terhadap kitar 
replikasi virus herpes  simpleks jenis 1 (HHV1) dan kebolehjangkitan progeni. Dua belas sebatian yang kebanyakannya 
terdiri daripada kumpulan flavonoid dan fenolik telah dikenal pasti melalui analisis kromatografi cecair-beriring 
spektrometri jisim (LC-MS/MS). Kesan terhadap fasa replikasi HHV1 dikenal pasti melalui asai masa-penambahan, masa-
penyingkiran dan penurunan bilangan virus serta penentuan pengekspresan beberapa gen terpilih melalui tindak balas 
rantaian polimerase-kuantitatif masa nyata (qRT-PCR). Kesan perencatan ekstrak terhadap pembentukan plak paling 
tinggi semasa 2 dan 24 jam selepas jangkitan. Perencatan pembentukan plak juga dikesan pada semua masa ujian tetapi 
pada peratusan yang lebih rendah. Rawatan dengan E. indica menurunkan kebolehjangkitan progeni selepas dirawat 
selama 10 jam dan tindakannya bergantung kepada dos. Ekstrak metanol E. indica merencat fasa paling awal, awal 







jangkitan. Imuno-penandaan terhadap sel terjangkit mengesahkan E. indica menindas terutamanya glikoprotein B pada 
sel terjangkit tetapi bukan glikoprotein C dan D. Maka, ekstrak metanol E. indica berupaya mengubah kitar replikasi 
HHV1 pada setiap tahap replikasi dan menurunkan kebolehjangkitan progeni. 
Kata kunci: Ekstrak metanol Eleusine indica; kebolehjangkitan progeni; kitar replikasi HHV1
INTRODUCTION
Herpes simplex virus Type 1 (HHV1) is a double-stranded 
DNA virus in the Herpesviridae family. Worldwide 
prevalence of HHV1 infection was estimated in 2012 to be 
67% with highest prevalence in Africa, South-East Asia 
and Western Pacific (Looker et al. 2015). HHV1 is mainly 
transmitted by oral-oral contact causing oral herpes (cold 
sores) and genital herpes. The infection is asymptomatic 
but can lead to chronic or latent infection and end with 
fatality (Roizman et al. 2006).
 Acylovir (ACV) is the common antiviral agent used 
to treat HHV1 infection but drug resistance has developed 
in immunocompromised patients prophylactically treated 
with ACV for extended periods (Piret & Boivin 2011). 
ACV inhibits HHV1 replication by serving as a substrate 
for the viral DNA polymerase reaction that leads to the 
formation of incomplete DNA complex (Reardon & Spector 
1989). Resistance towards ACV can develop by frameshift 
mutations or nucleotide substitutions in the thymidine 
kinase (TK) viral gene resulting in different phenotypes 
(Gilbert et al. 2002). Thus, it is essential to develop new 
antiviral agents with a different mechanism of action from 
ACV. 
 Plants are important sources of antiviral lead 
molecules and Eleusine indica has been reported to have 
antiviral activity (Iberahim et al. 2016, 2015; Tahir et 
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al. 2014). Eleusine indica is an invasive grass species 
in the family Poaceae and has been used as folk remedy 
for skin problems. It has been indicated with antioxidant 
and anti-inflammatory activities (Sagnia et al. 2014). The 
methanol extract of E. indica is safe to cells (Iberahim et 
al. 2015), protect cells against viral infection, inhibits viral 
attachment and penetration and also has virucidal effect 
(Iberahim et al. 2016). This study was done to further 
determine the compounds in E. indica methanol extract 
and elucidate the antiviral effect with regards to in vitro 




Methanol extract of E. indica was prepared according to 
Iberahim et al. (2015). For antiviral treatment, a stock 
solution of 10 mg/mL was prepared by sonication of 
the extract in 1%, w/v DMSO and 99%, v/v of Dulbecco 
Modified Essential Medium (DMEM, Gibco. USA).
CELLS AND VIRUS
African green monkey kidney cells (Vero cells) and a 
clinical strain of HHV1 were obtained from the Virology 
Laboratory, Universiti Kebangsaan Malaysia stock 
collection. Vero cells were grown in DMEM supplemented 
with 5%, v/v Fetal Bovine Serum (FBS, Jr. Scientific. 
USA), 100 U/L of penicillin/streptomycin (Gibco. USA), 
non-essential amino acid (Gibco. USA 100×) and 20 U/L 
of amphostate B (Sigma-Aldich, USA). Cell culture was 
maintained in an incubator at 37°C and humidified with 
5% CO2 atmosphere. Virus titer was estimated using a 
standard plaque assay as described by Blaho et al. (2006). 
LIQUID CHROMATOGRAPHY-TANDEM MASS 
SPECTROMETRY (LC-MS/MS) ANALYSIS
Liquid Chromatography-Tandem Mass Spectrometry 
(LC-MS/MS) analysis of the E. indica methanol extract 
was performed on AB Sciex LCMSMS 3200QTrap system 
coupled to AgilentLC/MDSTrap VL for negative ionisation 
modes. Spectrum data with graph peaks between 100 and 
700 nm was recorded and processed by LCMSD software 
for data acquisition and analysis. 
TIME-OF-ADDITION ASSAY
The assay was followed as previously described by Cheng 
et al. (2006). Monolayer cells were infected with 100 pfu 
of virus and incubated at 37°C for 2 h. Eleusine indica 
methanol extract (0.3 mg/mL) was added at 2, 4, 6, 8 or 10 h 
post infection (hpi) followed by the addition of 1% methyl 
cellulose (MCS). Cells were further incubated at 37°C until 
24 hpi. Plaques were stained with crystal violet solution 
(0.4%, w/v) and the percentage of plaques inhibition was 
calculated using the following formula:
Percentage 
of plaque        =  
inhibition(%)     
TIME-REMOVAL ASSAY
The assay was done according to the procedure of Zhen et 
al. (2006) with modification of removal time. Confluent 
monolayers of Vero cell were infected with 100 pfu of 
HHV1 for 2 h at 37°C. Methanol extract of E. indica (0.3 
mg/mL) was added to the infected cells immediately 
after treatment. Medium containing the methanol extract 
was removed at 2, 4, 8, 10, 12, 14, 16, 18, 20, 22 and 24 
hpi, cells were washed twice with DMEM without FBS for 
one min and replaced with 1% MCS. Cells were further 
incubated for 48 h before staining with crystal violet 
solution (0.4%). The percentage of plaque inhibition was 
calculated using the formula as above.
VIRUS YIELD REDUCTION ASSAY
The assay was done according to the procedure by Saddi 
et al. (2007) with slight modification in the concentration 
used. Cells were infected with HHV1 at multiplicity of 
infection (MOI) = 1 for 2 h at 37°C. Infected cells were 
treated with different concentrations of methanol extract 
(0.1, 0.2, 0.3 and 0.4 mg/mL) and further incubated at 
37°C for 10 h. At the end of the incubation, infected cells 
were frozen at -80°C and thawed for five min repeatedly 
for three times. This was to ensure that virus in the infected 
cells stopped replicating. Cells were detached from 
wells by sonication for 15 min and the virus collected by 
centrifugation in the supernatant. The percentage of plaque 
inhibition by the virus released by the cells was titrated 
and calculated as above.
QUANTITATIVE REAL TIME - POLYMERASE 
CHAIN REACTION (QRT-PCR)
Quantitative RT-PCR was performed to determine the effect 
of E. indica methanol extract on the transcription of selected 
HHV1 genes at different replication stages. Confluent cells 
were infected with HHV1 at 0.1 MOI, treated with 0.3 mg/mL 
extract and the infected cells removed at 2, 8, 12, 20 and 24 
hpi. Viral RNA was extracted using viral RNA extraction kit 
(Tetra Viral RNA kit) and subjected to reverse transcription 
by Tetro cDNA treatment kit. The specific primers for 
qRT-PCR are listed in Table 1 which represented all three 
phases of HHV1 life cycle: Immediate early phase (UL54), 
early phase (UL30), late phase (UL 27); and housekeeping 
genes coding for Cyclophilin A and RPL- 32. Quantitative 
PCR (qPCR) was performed on a real-time PCR machine 
(Biorad iQ5, Invitrogen Life Science Technologies) using 
the following conditions: polymerase enzyme activation 
at 95°C for 10 min, followed by annealing process for 40 
cycles at 95°C for 15 s and elongation at 60°C for 1 min 
followed by a final melt curve analysis using instrument 
default settings. Gene expression of all the three genes in 
methanol extract-treated virus relative to the expression 
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in non-treated virus was calculated for each time point. 
Positive and negative controls were included in all runs.
IMMUNOFLUORESCENT STAINING
Confluent cells were seeded on confocal slits and virus 
infected at 0.1 MOI. Extract (0.3 mg/mL) was added and 
incubated at 4°C for 90 min. After incubation, cells were 
washed with phosphate buffered saline (PBS), followed 
by fixation in 4% paraformaldehyde for 30 min at room 
temperature (RT) and incubation with methanol at 20°C 
for 10 min. Cells were washed three times with PBS and 
followed by incubation with PBS-Triton X–FBS (PBTF) for 10 
min at RT. Cells were washed once with PBTF and blocked 
with FBS 10% for 90 to 120 min. Virus glycoprotein 
staining for gB, gC and gD was done by adding primary 
antibodies (anti-gB, anti-gC and anti-gD) in PBTF for 4 
h at RT. This is then followed by addition of secondary 
antibody conjugated with fluorescein isothiocyanate (FITC). 
Nucleus was stained with 4’, 6-diamidino-2-phenylindole 
(DAPI). Images were viewed at three random fields in two 
technical replicates for each treatment using a confocal 
microscope (Olympus ix2 ill 100).  
RESULTS
COMPOUNDS IN E. INDICA METHANOL EXTRACT
Thirty eight compounds were separated and determined 
by LC-MS/MS analysis from the E. indica methanol extract 
but only 12 compounds were identified (Table 2). Most 
of the compounds are from the flavonoid and phenolic 
groups. Several compounds found in the extract have 
been previously described as having antiviral activity. 
For example, Nakama et al. (2012) reported that caffeic 
acid inactivates HHV1 by blocking viral attachment and 
penetration into the host cell. Antraquinones display 
virucidal effect on enveloped virus such as HHV1 (Sydiskis 
et al. 1991) and naringenin showed a moderate antiviral 
effect towards HHV1 (Lyu et al. 2005). The direct effect of 
E. indica methanol extract on the virus has been reported 
by Iberahim et al. (2016) that hampered virus absorption. In 
this study, polyphenols are present in the methanol extract 
as shown in the LC-MS/MS analysis. Contribution of this 
polyphenols to the virucidal activity is yet to be confirmed. 
Hydroxybenzoic acid derivatives in the presence of other 
compounds were able to inhibit 68.1% of plaque formation 
in HHV1 infection (Kamel et al. 2010). In addition, 
the methanol extract may also contain cytoprotective, 
antioxidant and anti-inflammatory substances (Table 2). 
ELEUSINE INDICA IS EFFECTIVE DURING EARLY 
STAGE OF HHV1 REPLICATION
Time-of-addition assay was performed to determine the 
effect of E. indica when added at different times beginning 
from the time of infection and at 2 h interval until 10 hpi. 
Figure 1 shows that 75% of plaque inhibition occurred 
when E. indica was added during the first 2 h post infection 
and declined to more than 50% at 6 hpi. This observation is 
parallel to the results in our previous study which showed 
that E. indica prevented virus attachment and penetration 
(Iberahim et al. 2016) which represent the early stage of 
HHV1 replication cycle. 
 Time-removal assay was conducted from the 
beginning of infection (2 hpi) until the end of late phase in 
HHV1 replication cycle (26 hpi). Plaque inhibition (40%) 
occurred starting from 2 hpi to 79% inhibition at 12 hpi 
(Figure 2). Decrease in plaque inhibition occurred after 
12 to 20 hpi at 39% but increased to 73% at 24 hpi. This 
implies that E. indica inhibits the attachment, penetration 
and early phase of virus replication as indicated in the time-
of-addition assay but does not affect progeny packaging or 
late phase of virus replication. However, the extract was 
able to alter and reduce the level of infectivity in progeny 
that is released from the infected cells as observed at 24 hpi. 
To further confirm this observation, virus yield reduction 
assay was performed. 
ELEUSINE INDICA REDUCES VIRUS YIELD 
AND PROGENY INFECTIVITY
Virus-infected cultures were incubated with E. indica 
methanol extract for a period sufficient to permit virus 
replication and assayed for the presence of new progeny 
virus by titration on separate monolayer cultures. Figure 
3 shows that the progeny infectivity was reduced to 43% 
using 0.3 mg/mL extract after 10 h of treatment and dose-
dependent. The virucidal activity of E. indica methanol 
extract has been indicated previously (Iberahim et al. 
2016). Furthermore, virus reinfection may have been 
reduced due to the modification of the released progeny 
by exposure to the extract thus inhibiting the attachment 
and penetration into cells. 
TABLE 1. Primers for virus and housekeeping genes and the annealing temperatures






UL54 GAC GGG TCT CCT GGG AAA C ATA ATG GGG TCC TGG GGG C 54.8 to 56.1
UL30 CGC CCC GCT CTG TTT TAC CCA GCC GAA GGT GAC GAA C 53.8 to 61.3
UL27 CGG TGG TTC GTC GTA TGG G GGC GGC GTT GGG TTT TTC 55 to 62.3
Cyclophilin A ATG GCA CTG GTG GCA AGT C ATT CCT GGA CCC AAA GCG 53.8 to 56.9
RPL-32 AAC ATT CCA TCT CCT CCT CGG TTG ACA TAC CGG TCT GAC TGG TGC 54.8 to 56.1
1434 
TABLE 2. List of compounds partially identified by LCMS/MS in Eleusine indica methanol extract and their associated biological activity. 
*Rt: Retention time; [M-H]− : Deprotonated ions of the standard compounds; MS2 : MRM fragments for the related molecular ions






1 Hydroxycinnamic acid 3.98 421 -
Cytoprotective effect by ultraviolet 
radiation exposure (Rungsimakan 
2011)
2 Naringenin (Flavanones) 4.435 267.2 133.0 Moderate anti-HSV-1 activity (Lyu 
et al. 2005)
3 2(3,4-Dihydroxyphenyl)-7-hydroxy-5-benzenepropanoic acid 8.657 311.55 311.3
Food preservatives with anti-
microorganism and antioxidant 
activity (Korneev 2013)
5 Antraquinone 11.518 269.54 269.3 Inactivate enveloped viruses (Sydiskis et al. 1991)
6 Caffeic acid derivative 1.022 377.05 377.2 HSV-1 virucidal effect (Nakama et al. 2012) 
7 Caffeoyl glucose 2.046 341.28 341.2
Cytoprotective effect by ultaviolet 
radiation exposure (Rungsimakan 
2011)







(Taheri Rouhi et al. 2017)
10 p-Coumaric acid (Hydroxycinnamic acids) 1.705 163.22 119.0
Anticancer, antioxidant (Ferguson 
et al. 2005) and anti-inflammatory 
(Kassim et al. 2010)
11 Chrysin 3.639 253.23 253.2 Anti-inflammation (Woo et al. 
2005)
12 Rhamnazin (Flavonols) 7.173 330.59 330.3
Antiproliferative and apoptogenic 
effects  (Philchenkov & Zavelevych 
2015)
FIGURE 1. The effect of E. indica methanol extract on plaque 
inhibition in time-of-addition assay
FIGURE 2. The effect of E. indica methanol extract on plaque 
inhibition in time-removal assay
ELEUSINE INDICA ALTERS UL54, UL30  AND UL27 GENES 
DURING HHV1 REPLICATION
Quantitative RT-PCR was employed to monitor transcription 
levels of the following viral genes including UL54, UL27 
and UL30 within 24 h of replication in Vero cells. Figure 4 
shows expression levels of the virus genes relative to the 
expression in non-treated samples at five different time 
points which represent different stages of virus replication: 
2 hpi to represent the immediate early phase, 8 and 12 
hpi for early phase and 20 and 24 hpi for late phase. 
Treatment with E. indica at 2 hpi causes down regulation 
of UL27 transcription in the immediate early phase. Down 
regulation of all three genes by the treatment was observed 
at 8 hpi (early replication phase) but at 12 hpi, only UL54 
and UL27 genes were up-regulated. At 20 hpi (late phase 
when viral progeny is estimated to be released), all three 
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genes were transcribed and not affected by the treatment. 
However, at 24 hpi, the transcription levels for UL30 and 
UL27 genes were up-regulated but UL54 gene was down-
regulated to less than 2 fold change relative to the non-
treated infected cell.
ELEUSINE INDICA INHIBITS MAINLY GLYCOPROTEIN B BUT 
NOT GLYCOPROTEIN C AND D
The effect of E. indica on the attachment process involving 
virus glycoproteins gB, gC and gD in immunofluorescent 
staining of infected and treated cells is showed in Figure 
5. Reduced gB expression was observed when treated with 
E. indica compared to non-treated samples (Figure 5(B) 
and 5(E)). The intensity in the non-treated infected cells 
(Figure 5(K)) was almost similar for gC-stained treated and 
infected cells (Figure 5(H)) and also in gD-stained cells 
(Figure 5(N) and 5(Q)). The immunofluorescent staining 
confirms that E. incida treatment does not influence gC 
and gD expressions. Staining with DAPI indicates nuclear 
staining for treated and infected cells were reduced (Figure 
5(A), 5(G), 5(M)) compared to non-treated and infected 
cells (Figure 5(D), 5(J) and 5(P)). 
DISCUSSION
In general, one replication cycle of HHV1 will be completed 
within 10 to 12 h (Honess & Roizman 1974). In this 
study, the virus showed visible plaques as early as 28 
h of infection. Plaque formation inhibition activity was 
demonstrated beginning from the time point when the virus 
attaches to the cell until the release of new progeny. From 
the time-removal assay, the percentage of plaque inhibition 
FIGURE 3. Viral yield reduction assay shows a dose-dependent pattern in plaque inhibition
FIGURE 4. Calculated relative expression in methanol extract treated virus relative to the expression of non-treated virus of UL54, 
UL27 and UL30 genes at 2, 8, 12, 20 and 24 hpi. At 2 hpi, UL27 was down-regulated but not UL54 and UL30. All three viral genes were 
down-regulated at 8 hpi and with obvious downregulation of UL54 (4-fold change). At 12 hpi only UL30 was down-regulated but not 
UL54 and UL30 (but less than 1-fold change). All the three genes were highly up-regulated more that 3-fold 
change compared to the initial value. At 24 hpi, only UL54 was down-regulated
1436 
increased from 2 until 12 hpi and slightly reduced until 20 
hpi. This indicates that treatment with E. indica affects 
all phases of viral replication. Effect of treatment with 
E. indica however was more noted during early and late 
phases indicated by more than 50% of plaque formation 
inhibition. These results are parallel to the inhibition of 
expression of UL54, UL30 and UL27 genes in qRT-PCR 
assay. In a normal HHV1 replication cycle, all respective 
genes will be up-regulated throughout the phases (Wagner 
et al. 2010). Specifically, UL54 was expressed increasingly 
throughout the replication phases and as early as 2 hpi. For 
UL30 that codes for DNA polymerase, transcription reached 
the maximum level during 5 to 7 hpi. As for UL27, higher 
transcription was noted in the late phase compared to the 
immediate early phase (Wagner et al. 2010). 
 According to Kratz et al. (2008), inhibition of the 
immediate early phases can be due to the modification and 
disruption of cell receptor and viral glycoproteins during 





















FIGURE 5. Representative images of Eleusine indica treated and non-treated virus infected cells 
immunofluorescence staining using DAPI (blue, panels A, D, G, J, M, P) and FITC conjugated 
to anti-gB (panels B, C, E,F), FITC conjugated to anti-gC (panels H, I, K, L) 
and FITC conjugated to anti-gD (panels N, O, Q, R)
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attachment and entry of virus. In this study, UL54 gene 
was chosen due to the observation by Wagner et al. (2010) 
that any changes to the expression level of this gene can 
affect the functions of other early and late genes including 
gC for viral attachment. In addition, UL54 is responsible 
in increasing DNA replication (Rice & Knipe 1990) and 
increasing the transcription of the late genes (Uprichard 
& Knipe 1996). Treatment with E. indica caused up-
regulation to more than 1 fold change of UL54 and UL30 
expressions during immediate early phase. Treatment 
with E. indica however did not alter the expression of gC 
as shown in the immunocytochemistry assay. Thus, the 
up-regulation of UL54 in immediate early phase does not 
affect the gC expression. Even though gC is not responsible 
directly for viral penetration, inhibition of it will generally 
reduce viral infection (Shukla & Spear 2001). 
 As for the UL27 gene that codes for gB, down-
regulation of more than 2 fold and parallel to the inhibition 
of gB expression were noted in the immunocytochemistry 
assay. Glycoprotein B is one of the important viral 
proteins responsible for the attachment and entry of virus 
into the cell (Spear & Longnecker 2003). To confirm 
the antiviral activity in an attachment assay carried 
out previously (Iberahim et al. 2015), the inhibition of 
gD was also studied. The penetration process of virus 
into a cell depends on the interaction between gD with 
other related glycoproteins such as gB, gH and gL at a 
certain amount (Butcher et al. 1990). On the other hand, 
incomplete formation of gD-gB-gH-gL complex could 
cause failure of the penetration process (Turner et al. 
1998). From the results obtained, it can be concluded that 
the inhibition of viral attachment and penetration by E. 
indica was not caused by gD inhibition. The most possible 
explanation on the ability of E. indica to cause failure to 
virus attachment is the down-regulation of gB expression 
which affects the formation of gD-gB-gH-gL complex. 
Down-regulation in UL27 and subsequent reduction in 
gB expression have also been observed in an experiment 
using the treatment of a HHV inhibitor PHA767491 (Hou 
et al. 2017).
 In HHV1 replication, UL30, UL54 and UL27 genes will 
be up-regulated throughout the phases. For early phase 
of virus replication at around 8 to 12 hpi, expression of 
UL30 gene was observed due to its function in viral DNA 
replication. This activity takes place in the nucleus and is 
closely related to UL54 transcription (Wagner et al. 2010). 
At 8 hpi, treatment with E. indica causes all three genes to 
be down-regulated. However, at 12 hpi UL30 expression 
continues to be down-regulated but UL54 and UL27 were 
slightly up-regulated by up to 2 fold change relative to 
non-treated virus infected cells. In short, expression of the 
early phase genes was down-regulated by E. indica extract 
at 8 hpi but does not affect UL54 and UL27 at 12 hpi.
 During the late phase of replication, all three genes 
were up-regulated reaching 3 to 13 fold change in treated 
and virus infected cells compared to the non-treated virus 
infected cells. However by 24 hpi, i.e. when it is estimated 
to be the time when the virus progeny is being released, 
down-regulation of UL54 and UL27 was noted. This is 
parallel to the results from the time-removal assay that 
demonstrated increase in plaque formation inhibition at 
24 and 26 hpi. Since it was noted previously that E. indica 
can be virucidal, inhibit virus attachment and penetration 
(Iberahim et al. 2016), continuous treatment prevents 
progeny from being released as supported by the results 
in virus yield and progeny infectivity. The downregulation 
of UL54 gene noted in this study may affect the progeny 
from causing infection to neighbouring cells.
CONCLUSION
The methanol extract of E. indica contains different 
pharmacologically active substances which demonstrate 
a multifacet process in intervention of the different steps 
of the virus replication phases. The extract also provided 
protection to cells from virus reinfection where progeny 
infectivity was reduced mainly by modification of the gB 
protein. Treatment with E. indica is effective at all HHV1 
replication phases but more pronounced during early and 
late phases. It is proposed that E. indica methanol extract 
be further evaluated in vivo for its therapeutic potential as 
an anti-HSV agent.
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